Ovarian and uterine leiomyosarcoma: Which one is the primary?

Research output: Contribution to journalArticle

Abstract

Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.

Original languageEnglish
JournalHormone Molecular Biology and Clinical Investigation
DOIs
Publication statusAccepted/In press - 1 Jan 2019

Fingerprint

Leiomyosarcoma
Menstruation
Leiomyoma
Anemia
Ovary
Immunohistochemistry

Keywords

  • leiomyosarcoma
  • malignancy
  • metastasis
  • ovarian cancer
  • uterus cancer

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Endocrinology

Cite this

@article{a1ceb3a07348494099e5e5ff8e5901a9,
title = "Ovarian and uterine leiomyosarcoma: Which one is the primary?",
abstract = "Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1{\%} of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.",
keywords = "leiomyosarcoma, malignancy, metastasis, ovarian cancer, uterus cancer",
author = "Shafiee, {Mohamad Nasir} and {Kah Teik}, Chew and {Md Zain}, {Reena Rahayu} and Kampan, {Nirmala @ Chandralega}",
year = "2019",
month = "1",
day = "1",
doi = "10.1515/hmbci-2019-0037",
language = "English",
journal = "Hormone Molecular Biology and Clinical Investigation",
issn = "1868-1883",
publisher = "Walter de Gruyter GmbH",

}

TY - JOUR

T1 - Ovarian and uterine leiomyosarcoma

T2 - Which one is the primary?

AU - Shafiee, Mohamad Nasir

AU - Kah Teik, Chew

AU - Md Zain, Reena Rahayu

AU - Kampan, Nirmala @ Chandralega

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.

AB - Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.

KW - leiomyosarcoma

KW - malignancy

KW - metastasis

KW - ovarian cancer

KW - uterus cancer

UR - http://www.scopus.com/inward/record.url?scp=85070626561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070626561&partnerID=8YFLogxK

U2 - 10.1515/hmbci-2019-0037

DO - 10.1515/hmbci-2019-0037

M3 - Article

AN - SCOPUS:85070626561

JO - Hormone Molecular Biology and Clinical Investigation

JF - Hormone Molecular Biology and Clinical Investigation

SN - 1868-1883

ER -